2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures

Journal of the American College of Cardiology

Volumn 67, Issue 5, 2016, Pages 558-587

  Drozda, Joseph P ^a   Ferguson, T Bruce ^a   Jneid, Hani ^a   Krumholz, Harlan M ^a   Nallamothu, Brahmajee K ^a   Olin, Jeffrey W ^a   Ting, Henry H ^a  

^a NONE

Author keywords

ACC AHA Performance Measures; coronary artery disease; health policy and outcome research; myocardial infarction; percutaneous coronary intervention; peripheral arterial disease; shared decision making; statins

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DECISION MAKING; ELECTRONIC HEALTH RECORD; EVIDENCE BASED MEDICINE; HEALTH CARE DISPARITY; HUMAN; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATIENT CARE; PATIENT COMPLIANCE; PATIENT PREFERENCE; PERCUTANEOUS CORONARY INTERVENTION; PERFORMANCE MEASUREMENT SYSTEM; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SECONDARY PREVENTION; SHARED DECISION MAKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; VOLUNTARY REPORTING; ADVISORY COMMITTEE; CARDIOLOGY; CARDIOVASCULAR DISEASES; HEALTH SERVICE; HYPERLIPIDEMIAS; MEDICAL SOCIETY; NEEDS ASSESSMENT; PATIENT CARE PLANNING; PROCEDURES; STANDARDS; TOTAL QUALITY MANAGEMENT; UNITED STATES;

ADVISORY COMMITTEES; AMERICAN HEART ASSOCIATION; CARDIOLOGY; CARDIOVASCULAR DISEASES; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; NEEDS ASSESSMENT; PATIENT CARE PLANNING; QUALITY IMPROVEMENT; SECONDARY PREVENTION; UNITED STATES;

EID: 84950259700     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.02.003     Document Type: Article

References (53)

1. 1 Bonow, R.O., Masoudi, F.A., Rumsfeld, J.S., et al. ACC/AHA classification of care metrics: performance measures and quality metrics: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol 52 (2008), 2113–2117.
2. 2 Spertus, J.A., Eagle, K.A., Krumholz, H.M., et al. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. J Am Coll Cardiol 45 (2005), 1147–1156.
3. 3 Spertus, J.A., Bonow, R.O., Chan, P., et al. ACCF/AHA new insights into the methodology of performance measurement. J Am Coll Cardiol 56 (2010), 1767–1782.
4. 4 Anderson, J.L., Heidenreich, P.A., Barnett, P.G., et al. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), 2304–2322.
5. 5 Stone, N.J., Robinson, J.G., Lichtenstein, A.H., et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63:25 pt B (2014), 2889–2934.
6. 6 Olin, J.W., Allie, D.E., Belkin, M., et al. ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease). Developed in collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation; the American Diabetes Association; the Society for Atherosclerosis Imaging and Prevention; the Society for Cardiovascular Magnetic Resonance; the Society of Cardiovascular Computed Tomography; and the PAD Coalition. J Am Coll Cardiol 56 (2010), 2147–2181.
7. 7 Krumholz, H.M., Anderson, J.L., Bachelder, B.L., et al. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non-ST-Elevation Myocardial Infarction). Developed in collaboration with the American Academy of Family Physicians and American College of Emergency Physicians. J Am Coll Cardiol 52 (2008), 2046–2099.
8. 8 Nallamothu, B.K., Tommaso, C.L., Anderson, H.V., et al. ACC/AHA/SCAI/AMA convened PCPI/NCQA 2013 performance measures for adults undergoing percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures, the Society for Cardiovascular Angiography and Interventions, the American Medical Association Convened Physician Consortium for Performance Improvement, and the National Committee for Quality Assurance. J Am Coll Cardiol 63 (2014), 722–745.
9. 9 Drozda, J., Messer, J.V., Spertus, J., et al. ACCF/AHA/AMA PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association Physician Consortium for Performance Improvement. J Am Coll Cardiol 58 (2011), 316–336.
10. 10 Normand, S.L., McNeil, B.J., Peterson, L.E., et al. Eliciting expert opinion using the Delphi technique: identifying performance indicators for cardiovascular disease. Int J Qual Health Care 10 (1998), 247–260.
11. 11 Kumar, A., Fonarow, G.C., Eagle, K.A., et al. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry. Crit Pathw Cardiol 8 (2009), 104–111.
12. 12 Rabus, S.A., Izzettin, F.V., Sancar, M., et al. Five-year follow-up of drug utilization for secondary prevention in coronary artery disease. Pharm World Sci 30 (2008), 753–758.
13. 13 Maddox, T.M., Chan, P.S., Spertus, J.A., et al. Variations in coronary artery disease secondary prevention prescriptions among outpatient cardiology practices: insights from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol 63 (2014), 539–546.
14. 14 Arnold, S.V., Spertus, J.A., Tang, F., et al. Statin use in outpatients with obstructive coronary artery disease. Circulation 124 (2011), 2405–2410.
15. 15 Smolderen, K.G., Spertus, J.A., Tang, F., et al. Treatment differences by health insurance among outpatients with coronary artery disease: insights from the National Cardiovascular Data Registry. J Am Coll Cardiol 61 (2013), 1069–1075.
16. 16 Shah, N.D., Dunlay, S.M., Ting, H.H., et al. Long-term medication adherence after myocardial infarction: experience of a community. Am J Med, 122, 2009 961–13.
17. 17 Borden, W.B., Redberg, R.F., Mushlin, A.I., et al. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention. JAMA 305 (2011), 1882–1889.
18. 18 Arnold, S.V., Kosiborod, M., Tang, F., et al. Patterns of statin initiation, intensification, and maximization among patients hospitalized with an acute myocardial infarction. Circulation 129 (2014), 1303–1309.
19. 19 Javed, U., Deedwania, P.C., Bhatt, D.L., et al. Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospita participating in Get With The Guidelines (GWTG). Am Heart J 161 (2011), 418–424.
20. 20 Roger, V.L., The quality of quality: is it time for new tools?. Circulation 129 (2014), 1270–1272.
21. 21 Libby, P., Ridker, P.M., Hansson, G.K., Progress and challenges in translating the biology of atherosclerosis. Nature 473 (2011), 317–325.
22. 22 Kashani, A., Phillips, C.O., Foody, J.M., et al. Risks associated with statin therapy: a systematic overview of randomized clinical trials. Circulation 114 (2006), 2788–2797.
23. 23 Baigent, C., Blackwell, L., Emberson, J., et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376 (2010), 1670–1681.
24. 24 Ioannidis, J.P., Lau, J., Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA 285 (2001), 437–443.
25. 25 Ethgen, M., Boutron, I., Steg, P.G., et al. Reporting of harm in randomized controlled trials evaluating stents for percutaneous coronary intervention. Trials, 10, 2009, 29.
26. 26 Ioannidis, J.P., Evans, S.J., Gotzsche, P.C., et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 141 (2004), 781–788.
27. 27 Nallamothu, B.K., Hayward, R.A., Bates, E.R., Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. Circulation 118 (2008), 1294–1303.
28. 28 Hayward, R.A., Hofer, T.P., Vijan, S., Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem. Ann Intern Med 145 (2006), 520–530.
29. 29 Krumholz, H.M., Hayward, R.A., Shifting views on lipid lowering therapy. BMJ, 341, 2010, c3531.
30. 30 Hayward, R.A., Krumholz, H.M., Three reasons to abandon low-density lipoprotein targets: an open letter to the Adult Treatment Panel IV of the National Institutes of Health. Circ Cardiovasc Qual Outcomes 5 (2012), 2–5.
31. 31 Tavazzi, L., Maggioni, A.P., Marchioli, R., et al. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372 (2008), 1231–1239.
32. 32 Kjekshus, J., Apetrei, E., Barrios, V., et al. Rosuvastatin in older patients with systolic heart failure. N Engl J Med 357 (2007), 2248–2261.
33. 33 Fellstrom, B.C., Jardine, A.G., Schmieder, R.E., et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 360 (2009), 1395–1407.
34. 34 Elwyn, G., Dehlendorf, C., Epstein, R.M., et al. Shared decision making and motivational interviewing: achieving patient-centered care across the spectrum of health care problems. Ann Fam Med 12 (2014), 270–275.
35. 35 Jackevicius, C.A., Mamdani, M., Tu, J.V., Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 288 (2002), 462–467.
36. 36 Ting, H.H., Brito, J.P., Montori, V.M., Shared decision making: science and action. Circ Cardiovasc Qual Outcomes 7 (2014), 323–327.
37. 37 Weymiller, A.J., Montori, V.M., Jones, L.A., et al. Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch Intern Med 167 (2007), 1076–1082.
38. 38 Krumholz, H.M., The new cholesterol and blood pressure guidelines: perspective on the path forward. JAMA 311 (2014), 1403–1405.
39. 39 Montori, V.M., Brito, J.P., Ting, H.H., Patient-centered and practical application of new high cholesterol guidelines to prevent cardiovascular disease. JAMA 311 (2014), 465–466.
40. 40 Coylewright, M., Branda, M., Inselman, J.W., et al. Impact of sociodemographic patient characteristics on the efficacy of decision aids: a patient-level meta-analysis of 7 randomized trials. Circ Cardiovasc Qual Outcomes 7 (2014), 360–367.
41. 41 Subherwal, S., Patel, M.R., Kober, L., et al. Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains. Circulation 126 (2012), 1345–1354.
42. 42 Haynes, R.B., Ackloo, E., Sahota, N., et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev, 2008 CD000011.
43. 43 Iuga, A.O., McGuire, M.J., Adherence and health care costs. Risk Manag Healthc Policy 7 (2014), 35–44.
44. 44 Peterson, E.D., Ho, P.M., Barton, M., et al. ACC/AHA/AACVPR/AAFP/ANA concepts for clinician patient shared accountability in performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol 64 (2014), 2133–2145.
45. 45 Mukhtar, O., Weinman, J., Jackson, S.H., Intentional non-adherence to medications by older adults. Drugs Aging 31 (2014), 149–157.
46. 46 Bailey, S.C., Oramasionwu, C.U., Wolf, M.S., Rethinking adherence: a health literacy-informed model of medication self-management. J Health Commun 18:Suppl 1 (2013), 20–30.
47. 47 Nielsen-Bohlman, L., Panzer, A.M., Kindig, D.A., Health Literacy: A Prescription to End Confusion. 2004, National Academies Press, Washington, DC.
48. 48 Zhang, N.J., Terry, A., McHorney, C.A., Impact of health literacy on medication adherence: a systematic review and meta-analysis. Ann Pharmacother 48 (2014), 741–751.
49. 49 Lehmann, A., Aslani, P., Ahmed, R., et al. Assessing medication adherence: options to consider. Int J Clin Pharm 36 (2014), 55–69.
50. 50 Physician Consortium for Performance Improvement. PCPI position statement: specification and categorization of measure exclusions: recommendations to PCPI work groups: Available at: http://www.ama-assn.org/ama/pub/physician-resources/physician-consortium-performance-improvement/about-pcpi.page?. Accessed January 6, 2015.
51. 51 American College of Cardiology. NCDR PINNACLE Registry. Available at: https://www.ncdr.com/WebNCDR/pinnacle/PINNACLErequestinfo. Accessed January 6, 2015.
52. 52 Office of the National Coordinator for Health Information Technology. Standards and interoperability framework: Available at: Available at http://www.siframework.org/. Accessed April 17, 2014.
53. 53 Wu, A.W., Kharrazi, H., Boulware, L.E., et al. Measure once, cut twice–adding patient-reported outcome measures to the electronic health record for comparative effectiveness research. J Clin Epidemiol 66 (2013), S12–S20.